Biogen Idec   3Q Revenues: $2.5 billion (+37%)   3Q Earnings: $857 million (+76%)   YTD Revenues: $7.1 billion (+42%)   YTD Earnings: $2.1 million (+47%)   Comments: TECFIDERA revenues were $787 million in the quarter, up from $286.4 million in 3Q13, and consisting of $638 million in U.S. sales and $149 million outside the U.S. TYSABRI revenues were $501 million, up 25%. U.S. sales were $275 million and $226 million outside the U.S. Interferon revenues, including AVONEX and PLEGRIDY, were $745 m...